These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19593884)

  • 1. [Biological markers in Alzheimer disease: what are the chances for less slow diagnosis?].
    Schraen-Maschke S; Dhaenens CM; Bombois S; Deramecourt V; Van Brussel E; Obriot H; Marzys C; Sergeant N; Maurage CA; Pasquier F; Sablonnière B; Buée L
    Rev Neurol (Paris); 2009 Apr; 165 Spec No 2():F97-103. PubMed ID: 19593884
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological markers for diagnosis of Alzheimer's disease].
    Takeda M; Tanaka T; Kudo T; Okochi M; Kamino A; Tagami S
    Seishin Shinkeigaku Zasshi; 2004; 106(12):1610-4. PubMed ID: 15770965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biomarkers in cerebrospinal fluid and blood in memory complaints].
    Zetterberg H; Andreasen N; Blennow K
    Lakartidningen; 2009 May 13-19; 106(20):1386-9. PubMed ID: 19585836
    [No Abstract]   [Full Text] [Related]  

  • 4. Alzheimer research forum live discussion: Making a BioMark on Alzheimer disease.
    J Alzheimers Dis; 2005 Mar; 8(4):393-9. PubMed ID: 16646143
    [No Abstract]   [Full Text] [Related]  

  • 5. Amyloid beta concentrations in older people with Down syndrome and dementia.
    Jones EL; Hanney M; Francis PT; Ballard CG
    Neurosci Lett; 2009 Feb; 451(2):162-4. PubMed ID: 19111900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European scientists push spinal taps for Alzheimer diagnosis.
    Sinha G
    Nat Med; 2006 Feb; 12(2):156. PubMed ID: 16462785
    [No Abstract]   [Full Text] [Related]  

  • 7. Does the white matter matter in Alzheimer disease and cerebral amyloid angiopathy?
    Lee JM; Markus HS
    Neurology; 2006 Jan; 66(1):6-7. PubMed ID: 16401835
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
    Freund-Levi Y; Hjorth E; Lindberg C; Cederholm T; Faxen-Irving G; Vedin I; Palmblad J; Wahlund LO; Schultzberg M; Basun H; Eriksdotter Jönhagen M
    Dement Geriatr Cogn Disord; 2009; 27(5):481-90. PubMed ID: 19439966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene diagnosis of Alzheimer's disease and related disorders].
    Tanaka S
    Rinsho Byori; 2000 Jul; 48(7):621-4. PubMed ID: 11051786
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.
    Shi J
    Neurology; 2007 Sep; 69(10):1063-4; author reply 1064-5. PubMed ID: 17785679
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid biomarkers in Alzheimer disease: a fractional improvement?
    Galasko D
    Arch Neurol; 2003 Sep; 60(9):1195-6. PubMed ID: 12975282
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevation of plasma beta-amyloid level by glucose loading in Alzheimer mouse models.
    Takeda S; Sato N; Uchio-Yamada K; Sawada K; Kunieda T; Takeuchi D; Kurinami H; Shinohara M; Rakugi H; Morishita R
    Biochem Biophys Res Commun; 2009 Jul; 385(2):193-7. PubMed ID: 19450564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A model system in cell culture shows pathogenic processes. Biochemical diagnosis in Alzheimer dementia].
    Lannfelt L; Jensen M; Froelich S; Basun H; Näslund J; Nordstadt C
    Lakartidningen; 1996 Jun; 93(24):2326-31. PubMed ID: 8684035
    [No Abstract]   [Full Text] [Related]  

  • 14. Substance in blood may reflect progression of AD.
    Am J Alzheimers Dis Other Demen; 2003; 18(6):330-1. PubMed ID: 14682079
    [No Abstract]   [Full Text] [Related]  

  • 15. Testing for Alzheimer's.
    Scott J
    Nature; 1993 Dec; 366(6455):502. PubMed ID: 8255283
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum copper: a biomarker for Alzheimer disease?
    Bush AI; Strozyk D
    Arch Neurol; 2004 May; 61(5):631-2. PubMed ID: 15148135
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer's biomarker initiative hits its stride.
    Miller G
    Science; 2009 Oct; 326(5951):386-9. PubMed ID: 19833956
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood-based biomarkers in Alzheimer disease.
    Laske C
    Arch Neurol; 2011 May; 68(5):685-6; author reply 686. PubMed ID: 21555651
    [No Abstract]   [Full Text] [Related]  

  • 19. [The amyloid beta protein generating mechanism simultaneously generates several other peptides in Alzheimer disease--discovery of new notch-beta peptide and the possibility of its use as a marker for the diagnosis of Alzheimer disease].
    Okochi M; Takeda M
    Seishin Shinkeigaku Zasshi; 2003; 105(1):87-96. PubMed ID: 12701215
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomarkers of dementia.
    Brækhus A
    Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2218. PubMed ID: 22085936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.